No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia
-
Published:2024-06
Issue:6
Volume:88
Page:106161
-
ISSN:0163-4453
-
Container-title:Journal of Infection
-
language:en
-
Short-container-title:Journal of Infection
Author:
Wei JiaORCID,
Uppal Aashna,
Nganjimi Christy,
Warr Hermione,
Ibrahim Yasin,
Gu QingzeORCID,
Yuan HangORCID,
Rahman Najib M.,
Jones Nicola,
Walker A. Sarah,
Eyre David W.
Reference33 articles.
1. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017;Roth;Lancet,2018
2. Increasing hospital admissions for pneumonia, England;Trotter;Emerg Infect Dis,2008
3. Pneumonia incidence trends in UK primary care from 2002 to 2017: population-based cohort study;Sun;Epidemiol Infect,2019
4. Increasing burden of community-acquired pneumonia leading to hospitalisation, 1998-2014;Quan;Thorax,2016
5. Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study;Millett;PLoS One,2013